ARC Group Successfully Concludes Capital Markets & M&A Forum Shenzhen 2025, Celebrating a Decade of Excellence

ARC Group Successfully Concludes Capital Markets & M&A Forum Shenzhen 2025, Celebrating a Decade of Excellence

ARC Group, a leading global investment banking and management consultancy firm, successfully hosted the Capital Markets & M&A Forum Shenzhen 2025 at the Mandarin Oriental Hotel, marking its 10th anniversary and reaffirming its commitment to fostering cross-border investment, financial innovation, and collaboration in one of China’s most dynamic financial hubs.

The event brought together 230  distinguished attendees, including senior executives, investors, legal and advisory professionals, and entrepreneurs. Against the backdrop of Shenzhen’s rapid rise as a financial innovation hub, the forum provided a timely platform for dialogue, cross-border collaboration, and forward-looking insights into global capital markets.

Celebrating ARC Group’s Growth and Vision

Since its founding in 2015, ARC Group has advised on over USD 1 billion in cross-border M&A transactions and has consistently ranked among the top global SPAC advisors. Headquartered in Hong Kong with offices across Mainland China, the United States, Southeast Asia, Europe, and the Middle East, the firm delivers integrated solutions in financial advisory, capital markets, and management consulting. Its wholly owned subsidiary, ARC Group Securities LLC, a U.S.-registered FINRA member broker-dealer, further strengthens its capital markets offering with firm commitment underwriting capabilities.

“As we celebrate our 10-year milestone, it is a privilege to bring this flagship forum to Shenzhen for the very first time,” said Crystal Zhang, Managing Partner at ARC Group. “This forum not only reflects our commitment to fostering dialogue in one of China’s most vibrant financial centers, but also strengthens our mission to connect global capital with opportunity.”

Program Highlights

The forum featured keynote addresses, sector-focused discussions, and panels exploring:

  • Global Listing Standards and Capital Market Outlook – analyzing regulatory shifts and opportunities for Chinese companies accessing U.S. markets.
  • IPO and M&A Readiness – best practices for governance, compliance, and investor positioning.
  • Entrepreneurial Growth & Exit Strategies – insights from startup to strategic sale or listing.
  • The Future of Cross-Border M&A in Asia – industry consolidation, investor participation, and high-growth sectors.
  • China 2030 and Southeast Asia – macroeconomic trends shaping regional expansion and supply chain realignment.

Speakers included ARC Group’s senior partners alongside leaders from China’s legal, audit, and corporate advisory sectors, providing attendees with practical strategies and real-world case studies.

Sponsors and Partners

ARC Group extends its appreciation to the event’s sponsors, whose expertise and support helped deliver a comprehensive perspective on cross-border capital markets and M&A:

  • MarcumAsia – Top-ranked independent accounting and advisory firm recognized for guiding Asia-based companies through IPOs, cross-border listings, audit, and compliance, with deep expertise in U.S. and international reporting.
  • Lucosky Brookman LLP – U.S.-based corporate law firm serving small- and mid-cap markets with offices nationwide, specializing in securities, M&A, and high-impact business transactions.
  • Hunter Taubman Fischer & Li LLC (HTFL) – Corporate and securities law firm with global experience across Asia, Latin America, the Middle East, and Europe, offering practical, cost-effective counsel to issuers, underwriters, and investors.
  • Ascent Investor Relations – Leading global investor relations and corporate communications firm with offices in New York, Beijing, Shanghai, Shenzhen, Singapore, and Kuala Lumpur, enhancing market visibility, investor confidence, and long-term value creation.
  • Loeb & Loeb LLP – International law firm with U.S. and Asia offices, renowned for capital markets, corporate transactions, intellectual property, and regulatory advisory for clients from emerging businesses to global enterprises.

Looking Ahead

The success of the Shenzhen edition reinforced the Capital Markets & M&A Forum as a premier platform for knowledge-sharing, networking, and deal-making. ARC Group remains committed to expanding its global footprint, deepening expertise in high-growth markets, and continuing to create value for clients and partners worldwide.

“As we look back on this milestone event, we are deeply grateful to everyone who made it possible,” said Carlos Lopez, COO of ARC Group. “Thank you to our valued clients, distinguished speakers, sponsors, and the ARC Group team for making the Shenzhen forum a memorable success. This gathering reflected not only the strength of our global network, but also our shared commitment to building long-term partnerships and driving innovation in capital markets and M&A world wide.”

For media inquiries, please contact:

Anna Sahlberg Carlsson
Marketing Manager
[email protected]

Continue reading

BioNexus Gene Lab Corp. (Nasdaq: BGLC) Secures $500 Million Equity Facility From ARC Group International to Support Expansion of Precision Diagnostics, CDMO Operations, and Therapeutic Commercialization

BioNexus Gene Lab Corp. (Nasdaq: BGLC) Secures $500 Million Equity Facility From ARC Group International to Support Expansion of Precision Diagnostics, CDMO Operations, and Therapeutic Commercialization

SHERIDAN, Wyo., Dec. 02, 2025 (GLOBE NEWSWIRE) — BioNexus Gene Lab Corp. (“BGLC” or the “Company”), an emerging provider of precision oncology diagnostics with expanding operations across Southeast Asia, today announced it has entered into a $500,000,000 Equity Purchase Agreement (the “Facility”) with ARC Group International Ltd. (“ARC”), a global investment bank and the parent […]
ARC Group Recognized Among Asias Top M&A Advisory Firms for 2025
ARC Group Recognized Among Asia’s Top Consulting Firms for 2025

Please complete this form to download the case study

This field is for validation purposes and should be left unchanged.
*Required before submission